Since AD is the most common form of age‐related neurodegenerative disorders, we first analyzed the expression of MeCP2 based on a GEO dataset GSE29378 and found that MeCP2 expression was downregulated in the hippocampus of AD patients (Figure 1a). Here, MECP2 is linked to Alzheimer disease.